REQUEST A DEMO
Total
USD $0.00
Search more companies

Next Pharma Sourcing S A S (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Next Pharma Sourcing S A S Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Next Pharma Sourcing S A S is an enterprise located in Colombia, with the main office in Bogota D.C.. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on September 15, 2010. There are currently 26 (2024) people employed by Next Pharma Sourcing S A S. The latest financial highlights indicate a net sales revenue increase of 62.11% in 2023. A growth of 28.43% was recorded in its total assets. In, 2023, the company’s net profit margin increased by 7.23%.

Headquarters
Calle 95 # 14 - 45 Oficina 601
Bogota D.C.; Bogota D.C; Postal Code: 0809

Contact Details: Purchase the Next Pharma Sourcing S A S report to view the information.

Basic Information
Total Employees:
Purchase the Next Pharma Sourcing S A S report to view the information.
Outstanding Shares:
Purchase the Next Pharma Sourcing S A S report to view the information.
Incorporation Date:
September 15, 2010
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Alternate Fiscal Auditor
Company Performance
Financial values in the chart are available after Next Pharma Sourcing S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
62.11%
Total operating revenue
64.1%
Operating profit (EBIT)
343.07%
EBITDA
334.32%
Net Profit (Loss) for the Period
384.58%
Total assets
28.43%
Total equity
56.02%
Operating Profit Margin (ROS)
11.52%
Net Profit Margin
7.23%
Return on Equity (ROE)
27%
Debt to Equity Ratio
-41.91%
Quick Ratio
0.56%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?